Innovation and High Technology Cooperation between Hungary and the United States
Roundtable Session on Innovation and High Technology Cooperation between Hungary and the United States.
Purpose: Share US experience in rapid commercialization of high technology products through an efficient innovation process and a reliance on private sector financing, in order to contribute to improved Hungarian innovation and identify new opportunities for high technology growth.
Workshop Presentations
Innovation Environment and Decision-Making for High Technology Development in Hungary
Dr. Miklós Boda, President, National Office of Research and Technology
The Unique Strength of the Hungarian Science Base
Dr. Nobert Kroó, Secretary General, Hungarian Academy of Sciences
What is Required for Innovation from the Industry Perspective, Synergy of the Public and Private Sectors
Dr. Gail Cassell, Vice President of Scientific Affairs, Eli Lilly
Mechanisms in Place at NIH to Stimulate Innovation; Translation from Lab to Private Sector and Attracting Industry Investment in Publicly-Funded Research
Dr. Mark L. Rohrbaugh, Director, Office of Technology Transfer, National Institutes of Health
Introduction of Hungarian Presentations and Overview of the Hungarian Information Technology Sector
Mr. Mihály Jambrik, State Secretary, Ministry of Informatics and Communications
Overview of the Hungarian Information Technology Sector (Further Observations)
Dr. Balázs Szekfu, Director, Hungarian Association of IT Companies and Founder/Member of the Board, Carnation, Ltd.
Overview of the Hungarian Biotechnology Sector
Dr. Erno Duda, President, Hungarian Biotechnology Association
Dr. Ã?gnes Szmolenszky, Project Manager, Agricultural Biotechnology Center, Gödöllo
Overview of the Hungarian Pharmaceutical Research Sector
Dr. Ã?dám Vas, President, Science and Engineering Committee, Hungarian Association of Pharmaceutical Companies
Prof. Péter Mátyus, Head of Dept. of Organic Chemistry, Semmelweis University; President, Organic and Medicinal Chemistry Division, Hungarian Pharmaceutical Society
Overview: Moving from Idea to Market Place
Dr. George Atkinson, Science and Technology Adviser to the Secretary of State, US Department of State
Successful Innovation; Policies and Actions at the National Level
Dr. Robert T. Sienkiewicz, Senior Advisor to the Director, Advanced Technology Program, National Institutes of Standards and Technology
Early Stage Project Funding and Conditions that Attract Venture Capital
Ms. Linda Powers, Co-Founder/Managing Director, Toucan Capital Corporation
Incentives and Conditions that Draw Private Investment into Research and Development Projects
Mr. Thomas Weithman, Vice President Entrepreneurship and Investment Services, Virginia’s Center for Innovative Technology







